Cargando…

Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment

NSCLC (non-small cell lung cancer) is a leading cause of cancer-related deaths worldwide. Clinical trials showed that Hiltonol, a stable dsRNA representing an advanced form of polyI:C (polyinosinic-polycytidilic acid), is an adjuvant cancer-immunomodulator. However, its mechanisms of action and effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Shu-Chun, Zhang, Bo-Xiang, Su, Emily Chia-Yu, Wu, Wei-Ciao, Hsieh, Tsung-Han, Salazar, Andres M., Lin, Yen-Kuang, Ding, Jeak Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915988/ https://www.ncbi.nlm.nih.gov/pubmed/33562773 http://dx.doi.org/10.3390/ijms22041626

Ejemplares similares

Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
por: Barnard, Dale L., et al.
Publicado: (2011)

Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol(®) (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model
por: Kumaki, Yohichi, et al.
Publicado: (2017)

nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer
por: Lee, Eun Kyung, et al.
Publicado: (2016)

Modulation of lytic molecules restrain serial killing in γδ T lymphocytes
por: Sandoz, Patrick A., et al.
Publicado: (2023)

Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2023)

Tumor suppressor p53 restrains cancer cell dissemination by modulating mitochondrial dynamics
por: Phan, Trinh T. T., et al.
Publicado: (2022)

Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer
por: Zhang, Yujie, et al.
Publicado: (2020)

Inhibition of PKR by Viruses
por: Cesaro, Teresa, et al.
Publicado: (2021)

Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV
por: Duan, Yantao, et al.
Publicado: (2014)

Porcine enteric alphacoronavirus Inhibits IFN-α, IFN-β, OAS, Mx1, and PKR mRNA Expression in Infected Peyer's Patches in vivo
por: Xu, Zhichao, et al.
Publicado: (2020)

The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication
por: Clerzius, Guerline, et al.
Publicado: (2013)

miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1
por: Wu, Yi-Hui, et al.
Publicado: (2021)

PKR involvement in Alzheimer’s disease
por: Hugon, Jacques, et al.
Publicado: (2017)

PKR: A Kinase to Remember
por: Gal-Ben-Ari, Shunit, et al.
Publicado: (2019)

Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver
por: Liu, Lei, et al.
Publicado: (2021)

Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression
por: Wu, Tianqi, et al.
Publicado: (2022)

Interaction of PKR with single-stranded RNA
por: Mayo, Christopher B., et al.
Publicado: (2017)

Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment
por: Yang, Min, et al.
Publicado: (2020)

Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance
por: Wang, Changxu, et al.
Publicado: (2022)

Drug Cocktail Optimization in Chemotherapy of Cancer
por: Preissner, Saskia, et al.
Publicado: (2012)

In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)

GDF11 restrains tumor growth by promoting apoptosis in pancreatic cancer
por: Liu, Yanzhe, et al.
Publicado: (2018)

Okadaic acid activates the PKR pathway and induces apoptosis through PKR stimulation in MG63 osteoblast-like cells
por: HANEJI, TATSUJI, et al.
Publicado: (2013)

PKR Promotes Oxidative Stress and Apoptosis of Human Articular Chondrocytes by Causing Mitochondrial Dysfunction through p38 MAPK Activation—PKR Activation Causes Apoptosis in Human Chondrocytes
por: Ma, Ching-Hou, et al.
Publicado: (2019)

Activation of the Antiviral Kinase PKR and Viral Countermeasures
por: Dauber, Bianca, et al.
Publicado: (2009)

Contribution of dsRBD2 to PKR Activation
por: Hesler, Stephen, et al.
Publicado: (2021)

To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions
por: Müller, Nils Christian, et al.
Publicado: (2022)

Metastasis Suppressors and the Tumor Microenvironment
por: Bodenstine, Thomas M., et al.
Publicado: (2008)

Gelsolin suppresses gastric cancer metastasis through inhibition of PKR-p38 signaling
por: Yuan, Xiangliang, et al.
Publicado: (2016)

Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer
por: Supuramanian, Sathammai Sathappa, et al.
Publicado: (2023)

On the silicon diodes, types OA 200 and OA 202
por: Mulder, P B
Publicado: (1958)

Chinese herbal medicine anticancer cocktail soup activates immune cells to kill colon cancer cells by regulating the gut microbiota-Th17 axis
por: Nie, Xiaoli, et al.
Publicado: (2022)

Liposome cocktail activator modulates hepatocytes and remodels the microenvironment to mitigate acute liver failure
por: Yin, Na, et al.
Publicado: (2022)

A Novel Signature of CCNF-Associated E3 Ligases Collaborate and Counter Each Other in Breast Cancer
por: Chang, Shu-Chun, et al.
Publicado: (2021)

PKR activation causes inflammation and MMP-13 secretion in human degenerated articular chondrocytes
por: Ma, Ching-Hou, et al.
Publicado: (2017)

Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition
por: Fernandes, Janaina
Publicado: (2016)

PKR modulates abnormal brain signaling in experimental obesity
por: Taga, Mariko, et al.
Publicado: (2018)

Role of PKR in the Inhibition of Proliferation and Translation by Polycystin-1
por: Tang, Yan, et al.
Publicado: (2019)

Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives
por: Miyai, Yuki, et al.
Publicado: (2020)

An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
por: Darini, Cedric, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_88ofu6kps5f99rkqgsarhdf0p5